Natrox® is a transformative therapy brought to market by Cambridge-based Inotec AMD to heal the most challenging wounds at unprecedented speed.
Natrox® is now the new global standard in healing acute and chronic wounds. It is setting an unprecedented benchmark: up to 90% of patients with acute and chronic wounds heal within 8-12 weeks. Patients all over the world are already being treated successfully and the company is continually securing reimbursement in key markets.
Natrox® is FDA 510(k) certified, CE (IIb) marked and already reimbursed in a number of markets. The patented technology developed at Cambridge University, UK extracts moisture from the ambient air and converts it to oxygen, supplying pure humidified oxygen locally to the wound bed under any dressing at a continuous flow rate.